Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OBSERVE: Biomarkers in Individuals at Risk for Prion Disease

NCT05124392 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05124392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05124392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OBSERVE: Biomarkers in Individuals at Risk for Prion Disease
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2017
Completion date
June 1, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cjd (creutzfeldt jakob disease), familial fatal insomnia, ffi, gss, prion diseases